通过乙基甲烷硫素突变在小谷物作物中靶向诱导局部病变(TILLING)种群的发展

Executive Industry Relevance

Developing high-frequency TILLING populations in small grain crops enables functional gene validation where transformation-based methods are limited. This approach supports target validation and phenotypic screening by generating allelic series for mechanistic de-risking. The Cel-1 assay provides a low-resource, reproducible method for mutation detection, facilitating early-stage screening and lead identification in crop improvement pipelines.

Strategic Applications in Biopharma R&D

Early Discovery & Target Validation

• Scientific Value: Enables interrogation of therapeutic hypotheses through allelic series generation in disease-relevant systems.
• Operational Value: Supports biological de-risking by linking genotype to phenotype in small grain models.
• Scientific Value: Enhances target confidence by enabling functional validation of genes of interest via mutation detection.

Screening & Assay Development

• Scientific Value: Prepares validated biological systems for downstream screening using PCR-based Cel-1 assay on agarose gel.
• Operational Value: Ensures assay standardization and reproducibility through optimized EMS dosage curves and 40–60% lethality targeting.
• Scientific Value: Enables quantitative dependent variable measurements via mutant pool deconvolution and zygosity determination.

Translational & Preclinical Research

• Scientific Value: Provides disease-relevant systems for studying gene function in small grain crops with observable mutant phenotypes.
• Operational Value: Supports translational biomarker alignment by connecting molecular lesions to phenotypic outcomes.
• Scientific Value: Facilitates preclinical model development through stable M2 populations derived from selfed M1 lines.

Pipeline & Workflow Integration

The method integrates into early discovery workflows by enabling hypothesis testing, pathway clarification, and biological de-risking prior to lead identification.

• Discovery Biology: Supports hypothesis testing and pathway clarification via targeted mutation induction and detection in target genes.
• Screening: Delivers assay readiness and quantitative outputs through Cel-1-based mutation detection in pooled DNA samples.
• Analytics: Enables comparison of conditions via heteroduplex formation and cleaved band analysis on agarose gels.
• Translational Research: Connects to preclinical continuity through stable mutant lines with identifiable phenotypes for trait validation.
• Enterprise Reuse: Establishes a reusable mutagenesis platform applicable to any genotype for sustained genetic variation generation.

Operational & Enterprise Impact

• Scientific Value: Predictive confidence through high-frequency mutation spectra including missense, knockout, and splice variants.
• Operational Value: Standardization and scalability via dosage curve optimization and basic equipment-dependent Cel-1 assay.
• Strategic Value: Improved go/no-go decisions by reducing mechanistic ambiguity in gene function studies.
• Portfolio Impact: Risk-adjusted prioritization through access to allelic variants for crop improvement and trait validation.

Implementation Considerations

• Requires expertise in mutagenesis, DNA extraction, and PCR-based mutation detection.
• Dependent on thermal cyclers, spectrophotometers, and agarose gel electrophoresis systems.
• Necessitates cross-team standardization of EMS handling, DNA pooling, and Cel-1 reaction protocols.
• Requires adaptation across model systems via genotype-specific dosage curve development.
• Practical limitation: mutation detection sensitivity depends on heteroduplex formation and Cel-1 activity optimization.

Biopharma FAQs